Collection of Patient-Reported Symptoms and Performance Status Via the Internet
- Status
- COMPLETED
- Phase
- NA
Clinical Trials Related to Multiple Myeloma
Related studies linked through entity extraction aliases.
A Study of Bortezomib as Consolidation Therapy in Patients With Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE3
Consolidation Therapy With Bortezomib in Elderly Patients With Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE3
Hematopoietic Stem Cell Transplantation in Myeloma
- Status
- UNKNOWN
- Phase
- PHASE2/PHASE3
Phase I Study of Perifosine + Lenalidomide and Dexamethasone for Patients With Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1
Study of Azacitidine to Treat Relapsed or Refractory Multiple Myeloma
- Status
- TERMINATED
- Phase
- PHASE2
A Safety and Efficacy Study of CNTO 328 in Patients With B-Cell Non-Hodgkin's Lymphoma, Multiple Myeloma, or Castleman's Disease
- Status
- COMPLETED
- Phase
- PHASE1
Melphalan, Prednisone, Thalidomide and Defibrotide in Relapsed Multiple Myeloma Patients
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
An Efficacy and Safety Study of Siltuximab in Participants With Relapsed or Refractory Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
A Study of the Safety and Efficacy of CNTO 328 and Bortezomib to Bortezomib Alone in Patients With Relapsed or Refractory Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
Bortezomib-Dexamethasone-Doxorubicin-Study
- Status
- COMPLETED
- Phase
- PHASE2
Safety & Efficacy Study of Perifosine + Bortezomib +/- Dexamethasone for Multiple Myeloma Patients
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Epoetin Alfa in Treating Anemia in Patients Undergoing Chemotherapy for Multiple Myeloma
- Status
- COMPLETED
- Phase
- NA
ATRA Plus G-CSF for Mobilization of Hematopoietic Stem and Progenitor Cells
- Status
- COMPLETED
- Phase
- PHASE1
Simvastatin as Inhibitor of Cell Adhesion Mediated Drug Resistance in Patients With Refractory Multiple Myeloma.
- Status
- COMPLETED
- Phase
- PHASE2
Moxifloxacin in the Prevention of Bacteremia After High-dose Chemotherapy and Transplantation of Peripheral Stem Cells
- Status
- COMPLETED
- Phase
- PHASE3
Treatment With AMD3100 (Plerixafor) in MM Patients to Mobilize PBCs For Collection and for Transplantation
- Status
- TERMINATED
- Phase
- PHASE2
AMD3100 (Plerixafor) Given to NHL and MM Patients to Increase the Number of PBSCs When Given a Mobilizing Regimen of G-CSF
- Status
- COMPLETED
- Phase
- PHASE2
Melphalan, Prednisone, and CC-5013 (Revlimid) as Induction Therapy in Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
AMD3100 (Plerixafor) in Multiple Myeloma (MM) or Non-Hodgkin's Lymphoma (NHL) Patients Predicted to be Unable to Mobilize With G-CSF Alone
- Status
- TERMINATED
- Phase
- PHASE2